Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depth of Necrosis in Normal Cervix After 85% TCA
NCT04911075Completed
- Sponsor
- Universitas Indonesia
- Start
- Apr 2021
- Primary completion
- Oct 2021
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trichloroacetic acid in cervical intraepithelial neoplasia (CIN), sponsored by Universitas Indonesia. Primary endpoint: Depth of Cervical Epithelial Ablation at 30 days. Started Apr 2021; status: completed.
02
Drugs
trichloroacetic acid
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT04911075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04911075.